Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to diversify ahead of patent loss for its
November 14, 2025
US, EU to sign preliminary partnership deal on critical minerals on Friday
In El Salvador, shackled prisoners watch their mass trial on a big screen
Oil rises on concerns over escalating military tensions in the Middle East
Asia shares mixed, oil advances on US-Iran deadlock
Schlittler says heckling `not too bad' as he pitches at Fenway Park for first time against Red Sox
Hurricanes beat the Senators 2-1 to take a 3-0 series lead
McCollum ruins Knicks' night again, leading the Hawks to a 109-108 victory and a 2-1 lead